Efficacy of bepotastine besilate ophthalmic solution 1.5% for seasonal allergic conjunctivitis: A randomized, placebo-controlled, natural exposure, clinical trial

Author： Carr Warner W.   Nayak Anjuli S.   Ratner Paul H.   Gow James A.   McNamara Timothy R.   Williams Jon I.   for the Bepotastine Besilate Ophthalmic Solution 1.5 Bepreve Study Group  

Publisher： OceanSide Publications, Inc

ISSN： 1539-6304

Source： Allergy and Asthma Proceedings, Vol.34, Iss.3, 2013-05, pp. : 247-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Integrated phase III trials of bepotastine besilate ophthalmic solution 1.5% for ocular itching associated with allergic conjunctivitis

By Meier Edward J.   Torkildsen Gail L.   Gow James A.   McNamara Timothy R.   Gomes Paul J.   Williams Jon I.    

Allergy and Asthma Proceedings, Vol. 33, Iss. 3, 2012-05 ,pp. : 265-274

OceanSide Publications, Inc

Access to resources Recommend Favorite

Efficacy and Safety of Nedocromil Sodium 2% Ophthalmic Solution b.i.d. in the Treatment of Ragweed Seasonal Allergic Conjunctivitis

By Melamed Julian   Schwartz Robert H.   Blumenthal Malcolm N.   Zeitz Howard J.  

Allergy and Asthma Proceedings, Vol. 21, Iss. 4, 2000-07 ,pp. : 235-239

OceanSide Publications, Inc

Access to resources Recommend Favorite

Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study

By Yamamoto Hideyuki   Yamada Takechiyo   Kubo Seita   Osawa Yoko   Kimura Yuichi   Oh Myonmi   Susuki Dai   Takabayashi Tetsuji   Okamoto Masayuki   Fujieda Shigeharu  

Allergy and Asthma Proceedings, Vol. 31, Iss. 4, 2010-07 ,pp. : 296-303

OceanSide Publications, Inc

Access to resources Recommend Favorite

MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled trial of efficacy and safety

By Meltzer Eli O.   LaForce Craig   Ratner Paul   Price David   Ginsberg David   Carr Warner  

Allergy and Asthma Proceedings, Vol. 33, Iss. 4, 2012-07 ,pp. : 324-332

OceanSide Publications, Inc

Access to resources Recommend Favorite

Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis

By Abelson Mark B.   Gomes Paul J.   Pasquine Terri   Edwards Michael R.   Gross Robert D.   Robertson Stella M.  

Allergy and Asthma Proceedings, Vol. 28, Iss. 4, 2007-07 ,pp. : 427-433

OceanSide Publications, Inc

Access to resources Recommend Favorite